Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Hoarding Behaviour and Eating Disorders Among Holocaust Survivors and Their Descendants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03772301
Recruitment Status : Not yet recruiting
First Posted : December 11, 2018
Last Update Posted : December 11, 2018
Sponsor:
Information provided by (Responsible Party):
Hillel Yaffe Medical Center

Brief Summary:
"Hoarding "is a common behavior among Holocaust survivors and is related to the traumatic events they have experienced, and we assume that storage behavior and eating disorders are related to future generations of Holocaust survivors.

Condition or disease
Hoarding Disorder

Layout table for study information
Study Type : Observational
Estimated Enrollment : 1000 participants
Observational Model: Ecologic or Community
Time Perspective: Prospective
Official Title: Evaluation of Hoarding Behaviour and Eating Disorders Among Holocaust Survivors and Their Descendants
Estimated Study Start Date : January 1, 2019
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : January 2022

Group/Cohort
Group 1
At least 200 Jewish Holocaust survivors of the first generation living in Germany and Israel - an equal number in each country
Group 2
The second generation, whose parents lived in Europe during the Second World War, now live in Germany (originating from Western and Eastern Europe) - at least 200 participants.
Group 3
Third generation of Jewish Holocaust survivors who participated in the first phase, currently living in Germany and Israel - at least 200 participants including at least 100 subjects in each country. These are adults only. The research program does not include children and adolescents



Primary Outcome Measures :
  1. Hoarding [ Time Frame: Three years ]
    Questionnaire that will follow behaviour over generations



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Jewish Holocaust survivors living in Germany and Israel Their direct offspring and their children (second and third generation)
Criteria

Inclusion Criteria:

  1. Jewish Holocaust survivors living in Germany and Israel who have expressed their written and written consent to participate in monitoring and testing, and who are able to answer the research questionnaires.

    • Their direct offspring and their children (second and third generation)

  2. The control population - non-Jewish subjects who are not the descendants of Holocaust survivors living in Germany who have expressed their written and oral consent to participate in monitoring and testing and who are able to answer the research questionnaires and whose parents were not imprisoned in the camps second.

Exclusion Criteria:

  • (Participants who do not agree to participate (did not sign informed consent form
  • Respondents who are unable to answer interviewer questions
  • Non-Jewish subjects whose parents were in camps (ie prisoner camps, labor camps, etc.) during the second war.
Layout table for additonal information
Responsible Party: Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier: NCT03772301    
Other Study ID Numbers: HYMC-0083-18
First Posted: December 11, 2018    Key Record Dates
Last Update Posted: December 11, 2018
Last Verified: December 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Feeding and Eating Disorders
Hoarding Disorder
Mental Disorders
Obsessive-Compulsive Disorder
Anxiety Disorders